Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (NCT07304102) titled 'Assessment of GORE(R) EXCLUDER(R) IBE Plus Stent Graft Performance in Patients Undergoing Endovascular Iliac Revascularization' on Dec. 23, 2025.
Study Type: Interventional
Study Design:
Allocation: Non-Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: W.L.Gore & Associates
Condition:
Common Iliac Artery Aneurysm
Aorto Iliac Aneurysm
Intervention:
Device: GORE(R) EXCLUDER(R) IBE Plus Stent Graft
Recruitment Status: Not recruiting
Phase: N/A
Date of First Enrollment: September 2026
Target Sample Size: 100
To know more, visit htt...